An expected surge in generic GLP-1s is anticipated to reshape not only pharmaceutical pricing and access but also the global MedTech ecosystem supporting drug delivery.
Rahul R Patil
Advertisement
Articles by Rahul R Patil
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
GSK Enters Exclusive Collaboration with SBP Group to Accelerate Bepirovirsen at Launch in Mainland China
2
The Insight Gap: Biopharma’s Hidden Risk in the Race Against the Patent Cliff
3
President Trump Planning to Fire FDA Commissioner Marty Makary: Report
4
Pharmaceutical Executive Daily: GSK Enters Collaboration to Support Launch of Bepirovirsen
5